Large-scale testing (Phase 3)Looking for participantsNCT04966481
What this trial is testing
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
Who this might be right for
HPV-unrelated Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine 81